ARDT

ARDT Ardent Health, Inc.

Stock · NYSE · United States · Healthcare · US03980N1072

NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Ardent Health, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price 17.30 USD +8.81%

52-week range 7.71 – 17.68

Dividend yield—

Market cap2.4B

NowoTrade score 51 Grade A

Price history

Daily prices in USD.

Updated 07 Nov 2026 10:07. Information, not advice.

Results

Next results 03 Mar 2027 in 116 days · 16:00 · estimate 0.35

Last results 0.38 vs 0.25 estimated 04 Nov 2026 · Beat +55.0%

Beat the estimate 8 of 10 2 missed · 0 in line · 6 beats in a row

Average surprise +40.4% reported against the estimate, last 10 quarters

Earnings per share: estimate and reported

Estimate Reported: beat Reported: miss In line

Quarterly results

Date	EPS estimate	EPS reported	Surprise	Result
03 Mar 2027 16:00	0.35	—	—	Upcoming
04 Nov 2026 16:00	0.25	0.38	+55.0%	Beat
04 Aug 2026 16:00	0.19	0.27	+44.0%	Beat
05 May 2026 16:00	0.18	0.30	+68.2%	Beat
04 Mar 2026 16:00	0.35	0.36	+4.5%	Beat
12 Nov 2025 16:00	0.42	0.83	+95.9%	Beat
05 Aug 2025 16:00	0.32	0.55	+69.1%	Beat
06 May 2025 16:00	0.21	0.19	-6.8%	Miss
26 Feb 2025 16:00	0.46	0.70	+53.4%	Beat
06 Nov 2024 17:00	0.29	0.24	-16.1%	Miss
14 Aug 2024 16:00	0.29	0.40	+37.3%	Beat

Annual results · USD

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2025	6.3B	+6.0%	135.8M	2.1%	0.96	-39.2%	258.6M
2024	6B	+10.3%	210.3M	3.5%	1.58	+313.2%	127.5M
2023	5.4B	+5.5%	53.9M	1.0%	0.38	-71.5%	84.3M
2022	5.1B	—	188.9M	3.7%	1.34	—	-189.5M
2021	—	—	—	—	—	—	—

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in USD, by week
Period	Opening price	High	Low	Closing price	Change	Volume
02 Dec 2024 – 06 Dec 2024	16.06	16.94	15.90	16.65	+4.19%	1,132,200
25 Nov 2024 – 29 Nov 2024	15.63	16.51	15.55	15.98	+0.95%	588,700
18 Nov 2024 – 22 Nov 2024	16.63	17.00	15.36	15.83	-4.70%	1,327,900
11 Nov 2024 – 15 Nov 2024	16.38	17.95	16.20	16.61	+1.47%	1,221,700
04 Nov 2024 – 08 Nov 2024	17.70	18.19	14.58	16.37	-7.51%	1,809,700
28 Oct 2024 – 01 Nov 2024	18.01	18.85	17.39	17.70	-0.23%	879,900
21 Oct 2024 – 25 Oct 2024	19.47	19.64	17.54	17.74	-9.21%	1,378,300
14 Oct 2024 – 18 Oct 2024	18.76	20.72	18.56	19.54	+2.95%	1,262,300
07 Oct 2024 – 11 Oct 2024	17.99	18.99	17.29	18.98	+5.50%	1,529,500
30 Sep 2024 – 04 Oct 2024	18.42	19.26	17.28	17.99	-1.69%	2,102,400
23 Sep 2024 – 27 Sep 2024	18.28	19.94	18.02	18.30	+0.11%	2,454,600
16 Sep 2024 – 20 Sep 2024	18.21	18.48	16.73	18.28	+0.72%	4,027,600
09 Sep 2024 – 13 Sep 2024	19.18	19.47	17.52	18.15	-5.42%	1,338,000
03 Sep 2024 – 06 Sep 2024	19.83	20.30	18.33	19.19	-3.23%	1,211,900
26 Aug 2024 – 30 Aug 2024	17.53	20.13	16.95	19.83	+14.82%	3,642,100
19 Aug 2024 – 23 Aug 2024	16.85	17.96	16.62	17.27	+1.95%	817,300
12 Aug 2024 – 16 Aug 2024	15.40	17.29	15.37	16.94	+8.31%	2,217,400
05 Aug 2024 – 09 Aug 2024	15.75	16.75	15.30	15.64	-9.70%	594,000
29 Jul 2024 – 02 Aug 2024	17.12	18.16	16.62	17.32	+0.46%	1,028,300
22 Jul 2024 – 26 Jul 2024	17.30	17.51	16.18	17.24	-0.35%	2,777,300
18 Jul 2024 – 19 Jul 2024	15.00	17.60	15.00	17.30	—	5,854,200

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

What Ardent Health (ARDT) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 07 Nov 2026 01:14
Ardent Health Sees SWB Expenses Decline as Cost Controls Improve in Q3, RBC Says (opens in a new tab) MT Newswires · 06 Nov 2026 17:05
Ardent Health, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 06 Nov 2026 11:01
Ardent Health (ARDT) Returned To Profit And Lifted Guidance, Is The Stock Already Above Fair Value? (opens in a new tab) Simply Wall St. · 06 Nov 2026 09:15
Lovelace parent turns $45 million profit, trims labor costs (opens in a new tab) Albuquerque Journal, N.M. · 06 Nov 2026 04:02
Ardent Health (ARDT) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 20:49
Ardent Health, Inc. (ARDT) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 05 Nov 2026 15:14
Ardent Health Partners Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 05 Nov 2026 11:58
Ardent Health, Inc. (ARDT) Beats Q3 Earnings and Revenue Estimates (opens in a new tab) Zacks · 04 Nov 2026 23:45
Ardent Health Reports Third Quarter 2026 Results (opens in a new tab) 04 Nov 2026 21:15
Ardent Health Raises FY2026 GAAP EPS Guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.463B Est (opens in a new tab) Benzinga · 04 Nov 2026 17:58
Ardent Health Partners Q3 EPS $0.31 Beats $0.22 Estimate, Sales $1.624B Beat $1.603B Estimate (opens in a new tab) Benzinga · 04 Nov 2026 17:18
Ardent Health (ARDT) Stock Looks Like A Bargain As It Gains 43% YTD (opens in a new tab) Simply Wall St. · 23 Oct 2026 01:19
How New Digital Chief Will Impact Ardent Health (ARDT) Stock (opens in a new tab) Simply Wall St. · 22 Oct 2026 23:19
Ardent Health's Divestment of St. Francis Campus Shows Asset's ROI Below Expectations, UBS Says (opens in a new tab) MT Newswires · 01 Oct 2026 16:40

Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 15.90 USD
Market cap: 2.4B
Exchange: NYSE
Country: United States
Sector: Healthcare
Industry: Medical Care Facilities
Currency: USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the score	Points	Why
Business growth Yearly growth of revenue and of earnings per share.	6.0 / 25	Revenue growth of 7.2% a year Earnings per share growth of -10.5% a year
Quality Return on equity, net margin and how stable the margins are.	12.9 / 25	ROE of 14%
Financial strength Net debt against operating earnings, interest cover and free cash flow.	15.0 / 20	Net debt is 3.0× EBITDA Free cash flow yield of 7.6%
Valuation Free cash flow yield and the P/E against its sector.	15.0 / 15	P/E 16.8 against 31.1 for its sector
Analysts How far the analysts' average target is from today's price.	0.0 / 10	Analysts' target is -26% from the price

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.

Figures

Valuation
Figure	Value	Reading	Sector median
P/E (trailing)	16.8×	Fair	31.09×
P/E (forward)	13.6×	Good	14.98×
Price / book	1.75×	Fair	3.94×
Price / sales	0.38×	Good	3.37×
EV / EBITDA	8.2×	Good	12.96×
Free cash flow yield	7.6%	Good	2.6%

Quality
Figure	Value	Reading	Sector median
Gross margin	59.1%	Good	59.2%
Operating margin	5.9%	Weak	7.4%
Net margin	2.3%	Weak	3.4%
Return on equity	13.5%	Fair	5.7%
Return on assets	4%	Fair	3.6%

Growth
Figure	Value	Reading	Sector median
Revenue growth / year	7.2%	Fair	10.8%
EPS growth / year	-10.5%	Weak	10.2%

Financial health
Figure	Value	Reading	Sector median
Debt / equity	1.27×	Fair	0.46×
Net debt / EBITDA	2.98×	Fair	1.5×
Interest cover	5.9×	Fair	3.26×
Current ratio	2.13×	Good	2.35×

Dividends
Figure	Value	Reading	Sector median
Payout of earnings	0%	Weak	0%
Payout of free cash flow (3 years)	0%	Weak	—

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Follow ARDT and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in